Fidelity Investments
SPRB

Fidelity Investments’s Spruce Biosciences SPRB Stock Holding History

Fidelity Investments’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.5K Buy
+343
New +$19.2K ﹤0.01% 4695
2024
Q2 		– Sell
-1
Closed -$81 – 5684
2024
Q1 		$81 Buy
+1
New +$254 ﹤0.01% 4991
2023
Q4 		– Hold
0
– -$82 – 5691
2023
Q3 		– Hold
0
– – – 4881
2023
Q2 		– Sell
-1
Closed -$111 – 5626
2023
Q1 		$111 Buy
+1
New +$186 ﹤0.01% 4892
2022
Q4 		– Sell
-6
Closed -$1K – 5623
2022
Q3 		$1K Hold
6
– – ﹤0.01% 4762
2022
Q2 		$1K Sell
6
-87
-94% -$11.1K ﹤0.01% 4826
2022
Q1 		$14K Sell
93
-1,434
-94% -$267K ﹤0.01% 4140
2021
Q4 		$511K Sell
1,527
-11,160
-88% -$3.32M ﹤0.01% 2795
2021
Q3 		$5.72M Sell
12,687
-3,122
-20% -$1.96M ﹤0.01% 2321
2021
Q2 		$13.3M Sell
15,809
-126
-0.8% -$134K ﹤0.01% 2001
2021
Q1 		$19.8M Buy
15,935
+11
+0.1% +$16.9K ﹤0.01% 1810
2020
Q4 		$29M Buy
+15,924
New +$26.4M ﹤0.01% 1546

Other funds holding SPRB

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return

Fidelity Investments's SPRB Position: Q2 2026 in Review

Fidelity Investments opened a new position in Spruce Biosciences (SPRB) in Q2 2026: 343 shares worth $18.5K. The stake represents ﹤0.01% of the portfolio and ranks #4695 among its holdings. This is a return to the name: Fidelity Investments previously reported a position in SPRB as recently as Q1 2024.

Fidelity Investments first reported a position in SPRB in Q4 2020 and has held it in 11 quarters since. The position peaked at $29M in Q4 2020. 64 funds tracked by Wall St. Rank hold SPRB as of Q2 2026.

  • Fidelity Investments held 343 shares of Spruce Biosciences worth $18.5K as of Q2 2026.
  • Spruce Biosciences was a new Fidelity Investments position in Q2 2026.
  • Spruce Biosciences made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #4695 holding.
  • Fidelity Investments first reported a position in Spruce Biosciences in Q4 2020 and has held it in 11 quarters since.
  • Fidelity Investments's Spruce Biosciences position peaked at $29M in Q4 2020.
  • 64 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.